Actively Recruiting
68Ga-DOTA-TATE PET/CT Imaging in NETs
Led by Centre de recherche du Centre hospitalier universitaire de Sherbrooke · Updated on 2024-07-18
5000
Participants Needed
2
Research Sites
313 weeks
Total Duration
On this page
Sponsors
C
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Lead Sponsor
U
Université de Sherbrooke
Collaborating Sponsor
AI-Summary
What this Trial Is About
This clinical trial is a pragmatic study aiming to evaluate the innocuity/safety profile of the PET radiotracer 68Ga-DOTA-TATE, and to establish the procedure as a routine standard-of-care diagnostic tool for all neuro-endocrine cancer patients. It is a single-center study, but with recruitment across all Canada. The trial is prospective, non-randomized, open-label and with no control group. The superiority of this procedure over the former standard-of-care (Octreoscan) was already established in previous and numerous studies across the world. As such, the current trial aims to gather data to further support the implementation of 68Ga-DOTA-TATE as the new standard-of-care for neuro-endocrine tumors (NET).
CONDITIONS
Official Title
68Ga-DOTA-TATE PET/CT Imaging in NETs
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical requisition for a 68Ga-DOTA-TATE PET/CT signed by a referring doctor
- Patients with suspected or proven tumors expressing somatostatin receptors
- Informed consent by patient or parents if patient is under 18 years old
You will not qualify if you...
- Pregnancy (not an absolute exclusion; requires detailed discussion and patient agreement)
- Patient refusal to participate
- Prior severe anaphylactic reaction to DOTA-TATE or somatostatin analogs
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Centre Intégré Universitaire de Santé et des Services Sociaux du Centre de l'Ouest de Montréal - Jewish General Hospital
Montreal, Quebec, Canada, H3T 1E2
Actively Recruiting
2
CHUS
Sherbrooke, Quebec, Canada, J1H 5N4
Actively Recruiting
Research Team
S
Stéphanie Dubreuil
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here